Chronic Care Center

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Thalassaemia2 trials
• Myelodysplastic syndromes1 trial
• Myeloproliferative neoplasms1 trial
• Sickle cell disease1 trial
• Type 2 diabetes1 trial

Phase

• Phase 33 trials

Status

• Recruiting2 trials
• Completed1 trial

Lead sponsor

• Novo Nordisk A/S2 trials
• Celgene1 trial

Running trials

• Recruiting

  A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  NCT06609226· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

  NCT04064060· Phase 3· Celgene· Source

  Contact: Ali Taher, Site 500

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Thalassaemia2 recruiting
• Myelodysplastic syndromes1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Sickle cell disease1 recruiting

Closed trials

• Completed

  A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes

  NCT04596631· Phase 3· Novo Nordisk A/S· Source